4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative...

Details 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative... 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative...

2006-11-14

2010-10-05

Coleman, Brenda L (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S593000

Reexamination Certificate

active

07807664

ABSTRACT:
A novel 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or a pharmaceutically acceptable salt thereof, which is useful as an agent for treating or preventing nocturia and/or diabetes insipidus, is provided.

REFERENCES:
patent: 5710150 (1998-01-01), Taniguchi et al.
patent: 6096735 (2000-08-01), Ogawa et al.
patent: 6096736 (2000-08-01), Ogawa et al.
patent: 6335327 (2002-01-01), Ogawa et al.
patent: 6340678 (2002-01-01), Matsuhisa et al.
patent: 6547395 (2003-04-01), Neal et al.
patent: 6642223 (2003-11-01), Ogawa et al.
patent: 7183271 (2007-02-01), Koshio et al.
patent: 2002/0049194 (2002-04-01), Ogawa et al.
patent: 2003/0087892 (2003-05-01), Ashworth et al.
patent: 0716083 (1996-06-01), None
patent: 0987264 (2000-03-01), None
patent: 1445253 (2004-08-01), None
patent: 8-301848 (1996-11-01), None
patent: 9-221475 (1997-08-01), None
patent: 9-221476 (1997-08-01), None
patent: 2926335 (1999-05-01), None
patent: 11-349570 (1999-12-01), None
patent: 2000-351768 (2000-12-01), None
patent: 3215910 (2001-08-01), None
patent: 2 137 760 (1999-09-01), None
patent: WO-95/06035 (1995-03-01), None
patent: WO 95/34540 (1995-12-01), None
patent: WO-97/22591 (1997-06-01), None
patent: WO-98/39325 (1998-09-01), None
patent: WO-99/06403 (1999-02-01), None
patent: WO-99/06409 (1999-02-01), None
patent: WO-00/46224 (2000-08-01), None
patent: WO-01/49682 (2001-07-01), None
patent: WO 03/042181 (2003-05-01), None
Del Tredici et al., Identification of Novel Selective V.sub.2 Receptor Non-Peptide Agonists, Biochemical Pharmacology, vol. 76, pp. 1134-1141, 2008.
European Search Report received Jun. 25, 2008, in corresponding application EP 04 72 9502.
Office Action received Aug. 31, 2007, in related application 2005136863.
Ogawa et al.; “Pharmaceutical Composition”; Patent Abstracts of Japan of JP 11-060488, Mar. 2, 1999.
Kondo et al., “Novel Design of Nonpeptide AVP V2 Receptor Agonists: Structural Requirements for and Agonist Having 1-(4-AminobenzoyI)-2,3,4,5-tetrahydro-1H-1-benzazepine as a Template,” J. med. Chem. (Nov. 2000) vol. 43, No. 23, pp. 4388-4397.
Canadian Office Action (2 pages) mailed Nov. 2, 2009, in corresponding application No. 2,521,492.
European Office Action (5 pages) mailed Feb. 23, 2010, in corresponding application No. 04 729 502.7.
Israeli Office Action (1 page) mailed Aug. 17, 2009, in corresponding application No. 171332.

Affiliated with

Also associated with

Rating

4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4201952